Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: A community-based observational study

References

• Eurosurveillance Editorial Team. EMCDDA publishes 2012 report on the state of the drugs problem in Europe. Euro Surveill. 2012;17:20315.
   PubMedGoogle Scholar
• Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med. 2005;353:1945–1954.
   PubMed Web of Science ®Google Scholar
• DiNubile MJ, Lipsky BA. Complicated infections of skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother. 2004;53(Suppl 2):ii37–ii50.
   PubMedGoogle Scholar
• Bassetti S, Battegay M. Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies. Infection. 2004;32:163–169.
   PubMed Web of Science ®Google Scholar
• Park HY, Kim CR, Huh IS, et al. Staphylococcus aureus colonization in acute and chronic skin lesions of patients with atopic dermatitis. Ann Dermatol. 2013;25:410–416.
   PubMed Web of Science ®Google Scholar
• Robicsek A, Beaumont JL, Peterson LR. Duration of colonization with methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2009;48:910–913.
   PubMed Web of Science ®Google Scholar
• Del Giudice P. Cutaneous complications of intravenous drug abuse. Br J Dermatol. 2004;150:1–10.
   PubMed Web of Science ®Google Scholar
• Spijkerman IJ, van Ameijden EJ, Mientjes GH, Coutinho RA, van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996;49:1149–1154.
   PubMed Web of Science ®Google Scholar
• Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis. 2008;8:120.
   PubMed Web of Science ®Google Scholar
• Badiaga S, Raoult D, Brouqui P. Preventing and controlling emerging and reemerging transmissible diseases in the homeless. Emerg Infect Dis. 2008;14:1353–1359.
   PubMed Web of Science ®Google Scholar
• Lloyd-Smith E, Kerr T, Hogg RS, Li K, Montaner JS, Wood E. Prevalence and correlates of abscesses among a cohort of injection drug users. Harm Reduct J. 2005;2:24.
   PubMedGoogle Scholar
• Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health. 2008;8:405.
   PubMed Web of Science ®Google Scholar
• Lorvick J, Kral AH, Seal K, Gee L, Edlin BR. Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am J Public Health. 2001;91:46–47.
   PubMed Web of Science ®Google Scholar
• Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30:579–581.
   PubMed Web of Science ®Google Scholar
• Phillips KT, Stein MD. Risk practices associated with bacterial infections among injection drug users in Denver, Colorado. Am J Drug Alcohol Abuse. 2010;36:92–97.
   PubMed Web of Science ®Google Scholar
• Pollini RA, Gallardo M, Hasan S, et al. High prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico. Int J Infect Dis. 2010;14(Suppl 3):e117–e122.
   PubMed Web of Science ®Google Scholar
• Bassetti S, Hoffmann M, Bucher HC, Fluckiger U, Battegay M. Infections requiring hospitalization of injection drug users who participated in an injection opiate maintenance program. Clin Infect Dis. 2002;34:711–713.
   PubMed Web of Science ®Google Scholar
• Murphy EL, DeVita D, Liu H, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis. 2001;33:35–40.
   PubMed Web of Science ®Google Scholar
• Palepu A, Tyndall MW, Leon H, et al. Hospital utilization and costs in a cohort of injection drug users. CMAJ. 2001;165:415–420.
   PubMed Web of Science ®Google Scholar
• Vlahov D, Sullivan M, Astemborski J, Nelson KE. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep. 1992;107:595–598.
   PubMed Web of Science ®Google Scholar
• Dwyer R, Topp L, Maher L, et al. Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug Alcohol Depend. 2009;100:9–16.
   PubMed Web of Science ®Google Scholar
• Fink DS, Lindsay SP, Slymen DJ, Kral AH, Bluthenthal RN. Abscess and self-treatment among injection drug users at four California syringe exchanges and their surrounding communities. Subst Use Misuse. 2013;48:523–531.
   PubMed Web of Science ®Google Scholar
• Smith ME, Robinowitz N, Chaulk P, Johnson KE. High rates of abscesses and chronic wounds in community-recruited injection drug users and associated risk factors. J Addict Med. 2015;9:87–93.
   PubMed Web of Science ®Google Scholar
• Mackenzie AR, Laing RB, Douglas JG, Greaves M, Smith CC. High prevalence of iliofemoral venous thrombosis with severe groin infection among injecting drug users in North East Scotland: successful use of low molecular weight heparin with antibiotics. Postgrad Med J. 2000;76:561–565.
   PubMed Web of Science ®Google Scholar
• Swisher LA, Roberts JR, Glynn MJ. Needle licker's osteomyelitis. Am J Emerg Med. 1994;12:343–346.
   PubMed Web of Science ®Google Scholar
• Deutscher M, Perlman DC. Why some injection drug users lick their needles: a preliminary survey. Int J Drug Policy. 2008;19:342–345.
   PubMed Web of Science ®Google Scholar
• Dahlman D, Håkansson A, Björkman P, Blomé MA, Kral AH. Correlates of skin and soft tissue infections in injection drug users in a syringe-exchange program in Malmo, Sweden. Subst Use Misuse. 2015;50:1529–1535.
   PubMed Web of Science ®Google Scholar
• Aitken CK, Higgs P. Severe vein damage caused by Temezepam injecting. Aust N Z J Public Health. 2002;26:79.
   PubMed Web of Science ®Google Scholar
• Barańska-Rybak W, Błażewicz I, Kakol M, Roter M, Nowicki R. Cutaneous manifestations of injectable drug use: hidden secrets. Cutis. 2014;93:185–187.
   PubMed Web of Science ®Google Scholar
• Feeney GF, Gibbs HH. Digit loss following misuse of temazepam. Med J Aust. 2002;176:380.
   PubMed Web of Science ®Google Scholar
• Jenkinson RA, Clark NC, Fry CL, Dobbin M. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? Addiction. 2005;100:197–205.
   PubMed Web of Science ®Google Scholar
• Partanen TA, Vikatmaa P, Tukiainen E, Lepäntalo M, Vuola J. Outcome after injections of crushed tablets in intravenous drug abusers in the Helsinki University Central Hospital. Eur J Vasc Endovasc Surg. 2009;37:704–711.
   PubMed Web of Science ®Google Scholar
• Yeo, AK, Chan CY, Chia KH. Complications relating to intravenous buprenorphine abuse: a single institution case series. Ann Acad Med Singapore. 2006;35:487–491.
   PubMed Web of Science ®Google Scholar
• Bouquié R, Wainstein L, Pilet P, et al. Crushed and injected buprenorphine tablets: characteristics of princeps and generic solutions. PLoS ONE. 2014;9:e113991.
   PubMed Web of Science ®Google Scholar
• Ho RC, Ho EC, Mak A. Cutaneous complications among i.v. buprenorphine users. J Dermatol. 2009;36:22–29.
   PubMed Web of Science ®Google Scholar
• Lankenau SE, Kecojevic A, Silva K. Associations between prescription opioid injection and Hepatitis C virus among young injection drug users. Drugs (Abingdon Engl). 2015;22:35–42.
   PubMedGoogle Scholar
• Rosenblum A, Parrino M, Schnoll SH, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend. 2007;90:64–71.
   PubMed Web of Science ®Google Scholar
• Hakansson A, Medvedeo A, Andersson M, Berglund M. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration. Eur Addict Res. 2007;13:207–215.
   PubMed Web of Science ®Google Scholar
• Winstock AR, Lea T, Sheridan J. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. Int J Drug Policy. 2008;19:450–458.
   PubMed Web of Science ®Google Scholar
• Imbert B, Cohen J, Simon N. Intravenous abuse of methylphenidate. J Clin Psychopharmacol. 2013;33:720–721.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Soft tissue infections among injection drug users—San Francisco, California, 1996–2000. MMWR Morb Mortal Wkly Rep. 2001;50:381–384.
   PubMedGoogle Scholar
• Bluthenthal RN, Watters JK. Multimethod research from targeted sampling to HIV risk environments. NIDA Res Monogr. 1995;157:212–230.
   PubMedGoogle Scholar
• Kral AH, Malekinejad M, Vaudrey J, et al. Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. J Urban Health. 2010;87:839–850.
   PubMed Web of Science ®Google Scholar
• Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710–718.
   PubMed Web of Science ®Google Scholar
• IBM Corp. IBM SPSS Statistics for Windows. Version 22.0. Armonk, NY: IBM Corp; 2013.
   Google Scholar
• Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994;271:115–120.
   PubMed Web of Science ®Google Scholar
• Johnson KM, Fibbi M, Langer D, Silva K, Lankenau SE. Prescription drug misuse and risk behaviors among young injection drug users. J Psychoactive Drugs. 2013;45:112–121.
   PubMed Web of Science ®Google Scholar
• Roy E, Arruda N, Bourgois P. The growing popularity of prescription opioid injection in downtown Montreal: new challenges for harm reduction. Subst Use Misuse. 2011;46:1142–1150.
   PubMed Web of Science ®Google Scholar
• Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch Dermatol. 1977;113:780–782.
   PubMedGoogle Scholar
• Wanke I, Skabytska Y, Kraft B, Peschel A, Biedermann T, Schittek B. Staphylococcus aureus skin colonization is promoted by barrier disruption and leads to local inflammation. Exp Dermatol. 2013;22:153–155.
   PubMed Web of Science ®Google Scholar
• Morrison A, Elliott L, Gruer L. Injecting-related harm and treatment-seeking behaviour among injecting drug users. Addiction. 1997;92:1349–1352.
   PubMed Web of Science ®Google Scholar
• Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51:253–63; discussion 267–268.
   PubMed Web of Science ®Google Scholar
• Roux P, Carrieri MP, Keijzer L, Dasgupta N. Reducing harm from injecting pharmaceutical tablet or capsule material by injecting drug users. Drug Alcohol Rev. 2011;30:287–290.
   PubMed Web of Science ®Google Scholar
• Zule, WA, Bobashev G. High dead-space syringes and the risk of HIV and HCV infection among injecting drug users. Drug Alcohol Depend. 2009;100:204–213.
   PubMed Web of Science ®Google Scholar
• Zule WA, Cross HE, Stover J, Pretorius C. Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries. Int J Drug Policy. 2013;24:1–7.
   PubMed Web of Science ®Google Scholar
• Phillips, KT, Altman JK, Corsi KF, Stein MD. Development of a risk reduction intervention to reduce bacterial and viral infections for injection drug users. Subst Use Misuse. 2013;48:54–64.
   PubMed Web of Science ®Google Scholar
• Phillips KT, Stein MD, Anderson BJ, Corsi KF. Skin and needle hygiene intervention for injection drug users: results from a randomized, controlled Stage I pilot trial. J Subst Abuse Treat. 2012;43:313–321.
   PubMed Web of Science ®Google Scholar